Navigation Links
Molecular 'clock' could predict risk for developing breast cancer
Date:5/13/2008

DALLAS May 14, 2008 A chemical reaction in genes that control breast cancer provides a molecular clock that could one day help researchers more accurately determine a womans risk for developing breast cancer and provide a new approach for treatment, UT Southwestern Medical Center researchers have found.

In a study published in todays issue of Cancer Epidemiology Biomarkers & Prevention, scientists from UT Southwestern show that the chemical process, called methylation, is strongly correlated with breast-cancer risk and with precancerous changes in the breast cells.

The researchers determined that methylation acts as a type of biological clock, indicating how many times a cell has divided. This information could aid researchers in determining an individuals cancer risk.

The more a cell has divided, the greater the risk for cancer, said Dr. David Euhus, professor of surgical oncology. Monitoring methylation levels could give researchers a way of seeing how often cells have divided and where a woman stands on that clock. Once the clock reaches a certain hour, breast cancer is more likely to ensue.

During methylation, small molecules called methyl groups attach themselves to a gene and turn off, or silence, the gene.

Previous studies by Dr. Euhus have shown that apparently normal breast cells from women with breast cancer had increased methylation of a tumor-suppressor gene called RASSF1A.

In the current study, Dr. Euhus wanted to see if methylation of RASSF1A and other genes increased over time during the years when the ovaries are actively secreting estrogen and progesterone each month.

Dr. Euhus and his team sampled cells from 164 women women with breast cancer, women at high risk of developing breast cancer, and women with a low risk for the disease. The researchers examined methylation levels of five tumor-suppressor genes whose job is to stop tumors from developing in the breast.

A computer program developed by Dr. Euhus was used to determine the breast-cancer risk for patients in the study. Dr. Euhus has written several interactive software tools for risk measurement, which are used by major cancer centers worldwide.

His findings indicate that methylation of RASSF1A and other genes increases steadily during the years of ovarian cycling up to about age 55 suggesting that methylation is, indeed, a molecular clock recording the history of cell divisions.

Interestingly, having children, which is known to reduce breast-cancer risk if it occurs early in life, was associated with a reduction in methylation for some genes, Dr. Euhus said.

Dr. Euhus says the clock is not always marching forward, and there are ways to turn it back.

Methylation can be stopped or slowed down, said Dr. Euhus, who also directs the Mary L. Brown Breast Cancer Genetics and Risk Assessment Program at the Harold C. Simmons Comprehensive Cancer Center. We found that having a baby set the clock backward and so did getting close to menopause. Things that are known to reduce breast-cancer risk may also turn the clock backward.

A test for methylation of tumor-suppressor genes is not commercially available and Dr. Euhus says additional research is necessary to fully understand the mechanism. For example, it is not clear whether tumor-suppressor gene methylation is simply a marker of prior cell divisions, or whether it can cause increased cell division, hastening the development of breast cancer.

Dr. Euhus said medications that interfere with methylation might provide a new approach for reducing breast-cancer risk.

Even if theres a lot of methylation, I cant tell for sure if a woman is going to develop breast cancer, Dr. Euhus said. However, if I took two women from our study and one had more methylation than the other, the one with more methylation was more likely to have already had breast biopsies for benign disease, or had already been diagnosed with breast cancer.

Measuring tumor-suppressor gene methylation might not work well to predict breast-cancer risk in all women. For women with a strong family history of breast cancer, the concept wont work because those breast cancers are associated with DNA repair issues and not methylation, Dr. Euhus said.


'/>"/>

Contact: Connie Piloto
connie.piloto@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related biology news :

1. Researchers discover molecular basis of a form of muscular dystrophy
2. Brown opens institute for molecular and nanoscale innovation
3. Argonne scientists develop techniques for creating molecular movies
4. Molecular basis for neurodegeneration in Ataxia telangiectasia
5. ESF conference probes waters mysterious interactions at molecular level
6. Power of molecular imaging reveals secrets of the heart
7. Computer simulations point to key molecular basis of cystic fibrosis
8. New edition of a classic molecular biology textbook from CSHL Press and Benjamin Cummings
9. Molecular Biology of the Cell celebrates 25 years of publication
10. Shilatifard Lab sheds light on molecular machinery required for translation of histone crosstalk
11. How molecular muscles help cells divide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Molecular 'clock' could predict risk for developing breast cancer
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
Breaking Biology News(10 mins):
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... Durham, NC (PRWEB) , ... June 23, 2016 , ... ... Odense University Hospital in Denmark detail how a patient who developed lymphedema after being ... (fat) tissue. The results could change the paradigm for dealing with this debilitating, frequent ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology: